Healthcare >> CEO Interviews >> September 13, 2002
CHRISTIAN S. SCHADE joined Medarex, Inc., in 2000 and is the Senior Vice
President, Finance and Administration and Chief Financial Officer.
Medarex's Technical Operations Department, responsible for all
development and manufacturing activities, also reports to Mr. Schade.
Prior to joining Medarex, Mr. Schade served as Managing Director at
Merrill Lynch in London where he was Head of the European Corporate
Funding Group and was responsible for certain capital markets activities
of Merrill Lynch's European corporate clients. He also held various
corporate finance and capital markets positions in New York and London
for both Merrill Lynch and JP Morgan. Mr. Schade holds an AB from
Princeton University and an MBA from the Wharton School of the
University of Pennsylvania. Profile
Then tell us something about the transgenic mice technology.
Mr. Schade: Medarex is a biopharmaceutical that has always
